serum; blood samples; cerebral fluid; CSF
BV2; SH-SY5Y
-
inflammation (promotes); immune regulation (promotes); pyroptosis (promotes); apoptosis (promotes); oxidative phosphorylation (other); other pathway/process (promotes); ceRNA regulation (promotes)
RT-qPCR; Clinical Sample Validation; Transfection; MTT; Annexin V/PI Flow Cytometry; ELISA; Western Blot; FISH / smFISH; Luciferase Reporter Assay; RNA Pull-Down; RIP (RNA Immunoprecipitation); Northern Blot; Bioinformatics Analysis
circHIPK3 was increased in serum/blood and CSF of PD patients and could be a potential target in the treatment of PD
circHIPK3 is up-regulated in serum/blood and CSF from PD patients and in LPS-induced PD-related cell models. It promotes neuroinflammation, microglial activation, pyroptosis, inflammatory cytokine release, and ROS production by sponging miR-124 and activating the STAT3/NLRP3 signaling pathway, suggesting potential therapeutic relevance in PD.
0.7618
CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p/STAT3/NLRP3 signaling pathway in Parkinson's disease.
combined biological and clinical study